COE BRIAN enters TALIS BIOMEDICAL CORP with 69.27K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.92K | Indirect |
| Common Stock | 2.56K | Indirect |
| Common Stock | 58.88K | Direct |
| Common Stock | 3.92K | Indirect |
| Total | 69.27K | 58.88K direct·10.39K indirect |
Stock Option (right to buy)
DirectUnderlying shares
24.17K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
50.64K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Series F-1 Preferred Stock
IndirectUnderlying shares
10.63K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
817.48K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
33.27K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Series E-1 Preferred Stock
IndirectUnderlying shares
12.04K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C-1 Preferred Stock
IndirectUnderlying shares
21.57K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
7.11K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
587.63K
Shares owned
N/A
Exercise price
6.25
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
34.97K
Shares owned
N/A
Exercise price
1.51
Expiration
—
Exercise window
—
Underlying
1.60M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 24.17K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 50.64K | N/A |
| Series F-1 Preferred Stock Indirect | Common Stock | — | — | 10.63K | N/A | |
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 817.48K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 33.27K | N/A |
| Series E-1 Preferred Stock Indirect | Common Stock | — | — | 12.04K | N/A | |
| Series C-1 Preferred Stock Indirect | Common Stock | — | — | 21.57K | N/A | |
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 7.11K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 6.25 | — | — | 587.63K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 1.51 | — | — | 34.97K | N/A |
| Total | 1.60M | 0.00 | ||||